BioSpace News Archive

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, the company’s artificial intelligence (AI) driven cancer detection technology, will be presented at the American Association for Cancer Research (AACR) Special Conference

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 38th annual J.P. Morgan Healthcare Conference

Verastem, Inc., a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, announced the grant of options to purchase 110,963 shares of its common stock to eight new employees.

AVEO Oncology announced the appointment of Erick Lucera as chief financial officer. Mr. Lucera will be responsible for managing all aspects of the Company’s financial and accounting functions.

Plus Therapeutics, Inc. issued the following Letter to Shareholders from Dr. Marc Hedrick, President and Chief Executive Officer..

ZyVersa’s lead renal candidate is VAR 200, a cholesterol efflux mediator for treatment of renal disease; Phase 2a clinical trial scheduled to begin Q1-2020 in patients with FSGS

More than 330 AI Use Cases Will Contribute to Market Growth Across 28 Industries with the Strongest Enterprise AI Opportunity in Automotive, Consumer, Financial Services, Telecommunications and Retail Sectors

Nephros, Inc. announced preliminary financial results for the fiscal year ended December 31, 2019.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has been approved by Chinese multinational conglomerate, Alibaba Group (“Alibaba”), to operate a Global Seller Account.

NuProbe Global and CarrierGene Biotech Co. Ltd. announced the successful completion of their recent merger and integration.